Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,238 | 581 | 99.0% |
| Education | $80.83 | 9 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,262 | 75 | $0 (2024) |
| Novo Nordisk Inc | $963.17 | 74 | $0 (2024) |
| Lilly USA, LLC | $781.25 | 76 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $563.49 | 37 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $533.11 | 36 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $532.68 | 34 | $0 (2024) |
| PFIZER INC. | $508.87 | 43 | $0 (2024) |
| Amgen Inc. | $357.76 | 27 | $0 (2024) |
| Allergan, Inc. | $298.55 | 19 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $280.22 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $564.84 | 30 | Novo Nordisk Inc ($101.47) |
| 2023 | $32.87 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($19.62) |
| 2020 | $1,884 | 122 | AstraZeneca Pharmaceuticals LP ($223.12) |
| 2019 | $1,888 | 154 | AstraZeneca Pharmaceuticals LP ($242.31) |
| 2018 | $1,724 | 123 | AstraZeneca Pharmaceuticals LP ($336.96) |
| 2017 | $2,225 | 159 | AstraZeneca Pharmaceuticals LP ($410.53) |
All Payment Transactions
590 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Gastroenterology | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 09/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Diabetes | ||||||
| 09/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Inflammation | ||||||
| 07/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Diabetes Care | ||||||
| 07/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 497 | 1,588 | $84,494 | $46,268 |
| 2022 | 14 | 599 | 1,457 | $87,376 | $50,307 |
| 2021 | 13 | 564 | 1,066 | $83,037 | $50,052 |
| 2020 | 13 | 458 | 766 | $69,513 | $37,946 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 555 | $74,925 | $40,366 | 53.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,740 | $1,570 | 90.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 137 | 262 | $1,310 | $1,271 | 97.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 76 | $2,280 | $646.80 | 28.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $540.00 | $529.20 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $510.00 | $499.80 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 52 | $780.00 | $495.04 | 63.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 44 | 558 | $1,674 | $435.10 | 26.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 20 | 20 | $600.00 | $416.10 | 69.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 18 | $135.00 | $39.60 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 524 | $70,740 | $40,632 | 57.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 16 | 16 | $2,320 | $2,101 | 90.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $1,800 | $1,424 | 79.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $3,250 | $1,210 | 37.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $870.00 | $823.02 | 94.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 130 | 257 | $1,285 | $761.34 | 59.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $720.00 | $684.89 | 95.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 30 | 30 | $750.00 | $632.70 | 84.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 42 | 65 | $975.00 | $613.47 | 62.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 14 | $1,330 | $532.54 | 40.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 50 | $1,500 | $298.66 | 19.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 26 | 362 | $1,086 | $273.46 | 25.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 17 | $510.00 | $249.57 | 48.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 32 | $240.00 | $70.94 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 492 | $66,160 | $40,043 | 60.5% |
About Dr. Michael Soler, MD
Dr. Michael Soler, MD is a Family Medicine healthcare provider based in Portland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1285901140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Soler, MD has received a total of $8,318 in payments from pharmaceutical and medical device companies, with $564.84 received in 2024. These payments were reported across 590 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,238).
As a Medicare-enrolled provider, Soler has provided services to 2,118 Medicare beneficiaries, totaling 4,877 services with total Medicare billing of $184,573. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Geriatric Medicine
- Location Portland, TX
- Active Since 11/21/2011
- Last Updated 10/17/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285901140
Products in Payments
- FARXIGA (Drug) $1,116
- TRULICITY (Drug) $444.96
- XARELTO (Drug) $392.92
- Ozempic (Drug) $307.04
- ENTRESTO (Drug) $280.22
- TRADJENTA (Drug) $279.65
- TOUJEO (Drug) $269.77
- CHANTIX (Drug) $256.84
- Victoza (Drug) $233.28
- JARDIANCE (Drug) $225.59
- JANUVIA (Drug) $212.88
- Saxenda (Drug) $190.40
- Aimovig (Biological) $189.50
- TRELEGY ELLIPTA (Drug) $179.80
- INVOKANA (Drug) $139.76
- XIFAXAN (Drug) $138.16
- UBRELVY (Drug) $137.26
- NUEDEXTA (Drug) $131.82
- SOLIQUA (Drug) $127.73
- Yupelri (Drug) $122.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Portland
Robert Gobbo, Md, MD
Family Medicine — Payments: $61,183
Roy Abraham, Md, MD
Family Medicine — Payments: $22,570
Maria Atkins, D.o, D.O
Family Medicine — Payments: $13,450
Sean Mccloy, M.d, M.D
Family Medicine — Payments: $11,465
Dr. Carson Bauder, Md, MD
Family Medicine — Payments: $8,507
Erik Szeto
Family Medicine — Payments: $7,005